| 原料品名 | Levocetirizine |
|---|---|
| 原料中文名称 | 左西替利嗪 |
| 英文别名 | [2-[4-[(R)-p-chloro-α-phenylbenzyl]-1-piperazinyl]ethoxy]acetic acid |
| 中文别名 | 左西替利嗪-D4;(R)-西替利嗪-D4;左西替利嗪盐酸盐;西替利嗪R异构体;左西替利;左西替立嗪;左西替利嗪;2-[2-[4-[(4-氯苯基)-苯基甲基]哌嗪-1-基]乙氧基]乙酸 |
| 化学名称 | 2-[2-[4-[(R)-(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid |
| 分子式 | C21H25ClN2O3 |
| 分子量 | 388.89 |
| CAS号 | 130018-77-8 |
| EINECS编号 | 暂无权限 |
| 结构式图片 | 暂无权限 |
供应商信息
| 企业名称 | Laurus Labs Private Ltd. |
|---|---|
| 地址 | 21,Jn Pharma City,Parawada,Visakhapatnam 531021,Ap,India |
| 国家/地区 | 印度 |
| 公司官网 | 暂无权限 |
| 公司联系电话 | 暂无权限 |
| 公司简介 | We develop innovative medicines that greatly improve health outcomes for patients with an unremitting focus on quality and affordability. We work with all the top 10 generic pharmaceutical companies in the world. We sell our APIs in 56 countries. Our major focus areas include anti-retroviral, Hepatitis C and Oncology drugs. Continuous innovation is the lifeblood of our business. Therefore, we undertake dedicated R&D in areas that have significant growth potential. We filed 257 patents in which we own 116 patents. We have commercialised 60+ products since inception across four distinct business units: Generics API, Generics FDF, Ingredients and Synthesis. |
| 备注 | 若未能联系上供应商，可在药智通发布求购信息(https://a.d4t.cn/GbmkGL)，或联系药智通客服17318480790（微信同号） |
扩展信息
